

Navigating medical travel to Brazil requires a comprehensive understanding of both its regional healthcare geography and its national regulatory framework. This destination intelligence checklist provides a structured approach for US and Canadian patients to evaluate primary medical hubs like São Paulo, Rio de Janeiro, and Goiânia, while outlining the distinct roles of national regulatory bodies such as ANVISA and the CFM. By applying this framework, international patients can organize their cross-border care logistics with greater clarity and precision.
> Medical Disclaimer: This article is editorial content and does not constitute medical advice. Always consult a qualified healthcare professional for medical guidance.
Coordinating cross-border healthcare requires more than simply booking a flight and scheduling a consultation. For US and Canadian patients seeking care in South America, successful medical travel depends on robust destination intelligence. This means understanding the geographical layout of a country’s healthcare system and the regulatory bodies that govern its medical practices.
According to the International Trade Administration, Brazil’s Unified Healthcare System (SUS) is the sole provider of health services for approximately 72% of the population. However, alongside this public system exists a highly developed private healthcare market. According to International Insurance, most major urban centers in Brazil feature private hospitals and clinics that operate independently of the public system, which is where international patients typically seek care.
Navigating this private sector requires a clear understanding of where specialized care is concentrated and how it is regulated. Aesthetica Health operates exclusively as a non-clinical coordination platform to assist patients in this process. We are not a clinic, hospital, or medical provider, and we do not rank doctors clinically or provide medical advice. Instead, we offer structured logistical support through our Network Access ($149) and Concierge Access ($499) programs.
Editorial analysis: By utilizing a structured checklist to evaluate regional hubs like São Paulo, Rio de Janeiro, and Goiânia, and by understanding the roles of regulatory agencies like ANVISA and the CFM, international patients can approach their medical travel with a sophisticated, organized framework.
Before evaluating specific cities or coordinating travel logistics, international patients must understand the foundational regulatory bodies that govern healthcare in Brazil, as well as the geographical distribution of private medical infrastructure.
Brazil’s healthcare sector is regulated by distinct federal entities that oversee different aspects of medical practice and product safety.
ANVISA (Agência Nacional de Vigilância Sanitária)
According to the Brazilian Health Regulatory Agency (Anvisa), this organization is an autarchy linked to the Ministry of Health and serves as the coordinator of the Brazilian Health Regulatory System. Its primary role is to execute the sanitary control of the production, marketing, and use of products and services subject to health regulation. According to Pure Global, ANVISA's jurisdiction covers medical devices, in vitro diagnostic devices, and pharmaceuticals.
For international patients, understanding ANVISA is crucial because it dictates which medical devices and medications are legally permitted for use in Brazil. According to Qserve Group, medical devices in Brazil are classified based on risk into four categories, ranging from Class I (low risk) to higher risk classifications. Furthermore, according to the Chambers and Partners Global Practice Guide, ANVISA frequently leverages evaluations from equivalent foreign regulatory authorities, including the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA), to modernize and streamline its health system.
CFM (Conselho Federal de Medicina)
While ANVISA regulates products, the CFM regulates practitioners. According to the Conselho Federal de Medicina, the CFM was founded in 1951 to meet the need for supervising and regulating medical practice in Brazil. It is the federal autarchy responsible for issuing medical licenses and maintaining the registry of board-certified specialists. According to the IBA Healthcare and Life Sciences Law Committee, the CFM also establishes the ethical guidelines for medical practice, including the regulations governing telemedicine and the electronic processing of patient data.
Editorial analysis: Brazil is a massive country, and its private healthcare infrastructure is not distributed evenly. Medical travel is generally concentrated in specific regional hubs, each offering distinct logistical environments for international patients.
São Paulo
Editorial analysis: São Paulo operates as the financial and medical epicenter of Brazil. It houses the highest concentration of private hospitals, specialized clinics, and medical research centers in the country. For US and Canadian patients, São Paulo offers an environment similar to major North American metropolitan centers, with extensive international flight connectivity and robust logistical infrastructure.
Rio de Janeiro
Editorial analysis: Rio de Janeiro combines a long-standing history of specialized elective care with a highly developed private medical sector. While it shares many of the complex care capabilities of São Paulo, its infrastructure is often integrated into a more tourism-oriented environment, which can influence how patients plan their recovery logistics and local transportation.
Goiânia
Editorial analysis: Located in the central-western region of Brazil, Goiânia has steadily emerged as a highly specialized medical hub. While it may lack the sheer scale of São Paulo, it offers a concentrated community of board-registered specialists and modern clinical facilities. Patients traveling to Goiânia often experience a more streamlined, localized logistical environment, though it may require connecting flights from major international airports.
To effectively navigate Brazil's regional hubs and regulatory standards, US and Canadian patients should follow a structured destination intelligence checklist.
Before committing to travel, ensure you understand the regulatory standing of your prospective care.
Editorial analysis: Select your destination based on the location of your chosen specialist and the logistical infrastructure of the city.
International travel requires strict adherence to federal entry protocols.
Editorial analysis: Cross-border care requires careful financial planning, as international transactions involve exchange rates and foreign transaction fees.
Managing cross-border logistics independently can be complex. Aesthetica Health provides structured frameworks to assist with this process.
When evaluating Brazil as a destination for selected care, international patients should be aware of several common logistical and regulatory pitfalls.
What is the difference between ANVISA and the CFM?
According to Pure Global, ANVISA is the national regulatory agency responsible for overseeing health products, including medical devices and pharmaceuticals. In contrast, according to the Conselho Federal de Medicina, the CFM is the federal council responsible for supervising, regulating, and licensing the practice of physicians in Brazil.
Why are São Paulo, Rio de Janeiro, and Goiânia considered primary medical hubs?
Editorial analysis: These cities are considered primary hubs because they possess the highest concentrations of private medical infrastructure, board-registered specialists, and logistical support systems (such as international airports and specialized recovery accommodations) necessary to facilitate cross-border care for international patients.
Do US and Canadian citizens need a visa to travel to Brazil for medical consultations?
According to the U.S. State Department, US citizens are required to have a valid tourist visa and a passport valid on the date of entry to travel to Brazil. Canadian citizens are subject to similar entry requirements and should verify current visa protocols with the Brazilian consulate prior to booking travel.
How does Aesthetica Health assist with destination intelligence?
Aesthetica Health operates as a non-clinical coordination platform. Through our Network Access ($149) and Concierge Access ($499) programs, we provide logistical frameworks, facilitate specialist matching, and coordinate consultation scheduling within Brazil's primary medical hubs. We do not provide medical advice or clinical endorsements.
Are consultation fees included in Aesthetica Health's coordination packages?
No. Aesthetica Health charges strictly for non-clinical coordination and network access. Consultation fees are separate, paid directly to the medical provider, and typically range from $100 to $300 or more, depending on the specific physician and the regional hub where they practice.